• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞及其衍生的外泌体:治疗女性生殖功能障碍的有吸引力的治疗方法。

Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.

机构信息

Department of Dentistry, Eastern Mediterranean University (EMU) Famagusta, North Cyprus Mersin 10, Famagusta, Turkey.

Department of Anatomy, Faculty of Medicine, University of Kyrenia, Kyrenia, Northern Cyprus.

出版信息

Mol Biol Rep. 2024 Nov 22;52(1):10. doi: 10.1007/s11033-024-10106-6.

DOI:10.1007/s11033-024-10106-6
PMID:39576370
Abstract

Infertility is a reproductive health problem in the male or female reproductive system. Traditional assisted reproductive technology (ART) has been unable to solve various cases of infertility for years. Clinical researchers have sought to treat infertility using new methods that are more effective and noninvasive than the old methods. Recently, Mesenchymal stem cells (MSCs) and MSCs-derived Exosomes (MSC-Exos) via paracrine activity play an important role in treating various causes of infertility and improving pregnancy outcomes. In this review, we focus on the roles of MSCs and MSC-Exos cell therapy in female infertility in the different types of female reproductive disorders.

摘要

不孕是男性或女性生殖系统的生殖健康问题。传统的辅助生殖技术(ART)多年来一直无法解决各种不孕病例。临床研究人员一直在寻求使用比旧方法更有效和非侵入性的新方法来治疗不孕。最近,间充质干细胞(MSCs)和间充质干细胞衍生的外泌体(MSC-Exos)通过旁分泌活性在治疗各种原因的不孕和改善妊娠结局方面发挥着重要作用。在这篇综述中,我们重点介绍了 MSCs 和 MSC-Exos 细胞疗法在不同类型女性生殖障碍中的女性不孕中的作用。

相似文献

1
Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: attractive therapeutic approaches for female reproductive dysfunction.间充质干细胞及其衍生的外泌体:治疗女性生殖功能障碍的有吸引力的治疗方法。
Mol Biol Rep. 2024 Nov 22;52(1):10. doi: 10.1007/s11033-024-10106-6.
2
Exploring the future potential of mesenchymal stem/stromal cells and their derivatives to support assisted reproductive technology for female infertility applications.探讨间充质干细胞及其衍生细胞在支持女性不孕不育应用的辅助生殖技术方面的未来潜力。
Hum Cell. 2023 Sep;36(5):1604-1619. doi: 10.1007/s13577-023-00941-3. Epub 2023 Jul 5.
3
Exosomes Derived from Mesenchymal Stem Cells: Therapeutic Opportunities for Spinal Cord Injury.间充质干细胞衍生的外泌体:脊髓损伤的治疗机会。
Bull Exp Biol Med. 2024 Apr;176(6):716-721. doi: 10.1007/s10517-024-06095-y. Epub 2024 Jun 18.
4
Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility.间充质干细胞作为治疗女性不孕症的生物器官
Cells. 2020 Oct 8;9(10):2253. doi: 10.3390/cells9102253.
5
Mesenchymal Stem Cell-Derived Exosomes as a Treatment Option for Osteoarthritis.间充质干细胞衍生的外泌体作为骨关节炎的一种治疗选择。
Int J Mol Sci. 2024 Aug 23;25(17):9149. doi: 10.3390/ijms25179149.
6
Novel Applications of Mesenchymal Stem Cell-derived Exosomes for Myocardial Infarction Therapeutics.间充质干细胞衍生的外泌体在心肌梗死治疗中的新应用。
Biomolecules. 2020 May 2;10(5):707. doi: 10.3390/biom10050707.
7
Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes in Spinal Cord Injury.间充质干细胞衍生外泌体在脊髓损伤中的治疗潜力
Mol Neurobiol. 2025 Jan;62(1):1291-1315. doi: 10.1007/s12035-024-04490-0. Epub 2024 Sep 23.
8
Exosomes Derived from Apelin-Pretreated Mesenchymal Stem Cells Ameliorate Sepsis-Induced Myocardial Dysfunction by Alleviating Cardiomyocyte Pyroptosis via Delivery of miR-34a-5p.源自阿片肽预处理间充质干细胞的外泌体通过递送miR-34a-5p减轻心肌细胞焦亡,改善脓毒症诱导的心肌功能障碍。
Int J Nanomedicine. 2025 Jan 17;20:687-703. doi: 10.2147/IJN.S498770. eCollection 2025.
9
Exosomes derived from mesenchymal stem cells.源自间充质干细胞的外泌体。
Int J Mol Sci. 2014 Mar 7;15(3):4142-57. doi: 10.3390/ijms15034142.
10
Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes as Nanomedicine for Peripheral Nerve Injury.间充质干细胞衍生的外泌体作为周围神经损伤的纳米医学的治疗潜力。
Int J Mol Sci. 2024 Jul 18;25(14):7882. doi: 10.3390/ijms25147882.

引用本文的文献

1
Assisted Reproductive Technology: A Ray of Hope for Infertility.辅助生殖技术:不孕症患者的一线希望。
ACS Omega. 2025 May 23;10(22):22347-22365. doi: 10.1021/acsomega.5c01643. eCollection 2025 Jun 10.
2
Exosomal insights into ovarian cancer stem cells: revealing the molecular hubs.外泌体对卵巢癌干细胞的见解:揭示分子枢纽
J Ovarian Res. 2025 Jan 31;18(1):20. doi: 10.1186/s13048-025-01597-3.

本文引用的文献

1
Granulosa cell insight: unraveling the potential of menstrual blood-derived stem cells and their exosomes on mitochondrial mechanisms in polycystic ovary syndrome (PCOS).颗粒细胞洞察:揭示月经血源性干细胞及其外泌体在多囊卵巢综合征 (PCOS) 中线粒体机制中的潜力。
J Ovarian Res. 2024 Aug 17;17(1):167. doi: 10.1186/s13048-024-01484-3.
2
Immunogenicity of mesenchymal stromal/stem cells.间充质基质/干细胞的免疫原性。
Scand J Immunol. 2023 Jun;97(6):e13267. doi: 10.1111/sji.13267. Epub 2023 Apr 3.
3
Efficacy and safety of mesenchymal stem cell therapy for ovarian ageing in a mouse model.
间充质干细胞治疗卵巢衰老小鼠模型的疗效和安全性。
Stem Cell Res Ther. 2024 Apr 3;15(1):96. doi: 10.1186/s13287-024-03698-0.
4
The remodeling of ovarian function: targeted delivery strategies for mesenchymal stem cells and their derived extracellular vesicles.卵巢功能重塑:间充质干细胞及其衍生的细胞外囊泡的靶向递送策略。
Stem Cell Res Ther. 2024 Mar 27;15(1):90. doi: 10.1186/s13287-024-03704-5.
5
Mesenchymal stem cell-derived exosomes: a promising alternative in the therapy of preeclampsia.间充质干细胞衍生的外泌体:子痫前期治疗中一种有前景的替代方法。
Stem Cell Res Ther. 2024 Feb 5;15(1):30. doi: 10.1186/s13287-024-03652-0.
6
Protective role of stem cells in POI: Current status and mechanism of action, a review article.干细胞在原发性卵巢功能不全中的保护作用:现状与作用机制,一篇综述文章
Heliyon. 2023 Dec 6;10(1):e23271. doi: 10.1016/j.heliyon.2023.e23271. eCollection 2024 Jan 15.
7
The heterogeneity of mesenchymal stem cells: an important issue to be addressed in cell therapy.间充质干细胞的异质性:细胞治疗中需要解决的一个重要问题。
Stem Cell Res Ther. 2023 Dec 20;14(1):381. doi: 10.1186/s13287-023-03587-y.
8
Immune and oxidative stress disorder in ovulation-dysfunction women revealed by single-cell transcriptome.单细胞转录组揭示排卵功能障碍女性的免疫和氧化应激紊乱。
Front Immunol. 2023 Dec 4;14:1297484. doi: 10.3389/fimmu.2023.1297484. eCollection 2023.
9
Tissue-specific populations from amniotic fluid-derived mesenchymal stem cells manifest variant in vitro and in vivo properties.羊水来源间充质干细胞的组织特异性群体表现出不同的体外和体内特性。
Hum Cell. 2024 Mar;37(2):408-419. doi: 10.1007/s13577-023-01008-z. Epub 2023 Dec 12.
10
Human umbilical cord mesenchymal stem cell-derived extracellular vesicles loaded with TFCP2 activate Wnt/β-catenin signaling to alleviate preeclampsia.人脐带间充质干细胞来源的细胞外囊泡负载 TFCP2 激活 Wnt/β-catenin 信号通路缓解子痫前期。
Int Immunopharmacol. 2023 Feb;115:109732. doi: 10.1016/j.intimp.2023.109732. Epub 2023 Jan 20.